BMY Stock Skids As Looming Generics Shadow Its Biggest Product – Investor's Business Daily
Business News
- BMY Stock Skids As Looming Generics Shadow Its Biggest Product Investor’s Business Daily
- Bristol-Myers hits a 52-week low despite Q3 beat Seeking Alpha
- Bristol Myers Squibb Reports Third Quarter Financial Results for 2021 Yahoo Finance
- Bristol Meyers Squibb Posts Earnings Beat and Lifts Guidance TheStreet
- Bristol Myers reports 10% quarterly sales growth as cancer drugs rebound Yahoo Finance
- View Full Coverage on Google News
Source: Business News